ALHC Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

1.00B

+42.76%

-0.070

+22.81%

1.20B

+29.91%

0.110

+148.31%

1.29B

+26.6%

0.150

+8.54%

Estimates Revision

The market is revising Upward the revenue expectations for Alignment Healthcare, Inc. (ALHC) for FY2025, with the revenue forecasts being adjusted by 1% over the past three months. During the same period, the stock price has changed by 18.40%.

Revenue Estimates for FY2025

Revise Upward

+1%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+34.14%

In Past 3 Month

Stock Price

Go Up

+18.40%

In Past 3 Month

9 Analyst Rating

Wall Street analysts forecast ALHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALHC is 19.50 USD with a low forecast of 17.51 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

2 Hold

0 Sell

Strong Buy

Current: 0.000

Low

17.51

Averages

19.50

High

23.00

Current: 0.000

Low

17.51

Averages

19.50

High

23.00

Piper Sandler

Jessica Tassan

upgrade

$20 -> $30

2026-01-06

New

Reason

Piper Sandler

Jessica Tassan

Price Target

$20 -> $30

2026-01-06

New

upgrade

Reason

Piper Sandler analyst Jessica Tassan raised the firm's price target on Alignment Healthcare to $30 from $20 and keeps an Overweight rating on the shares. The firm is updating its model to reflect strong AEP sales and retention during Q4 2025 and higher resulting membership in 2026. Piper also refined its 2027 estimates and added 2028-2030.

Baird

Outperform

maintain

$22

2025-12-29

Reason

Baird

Price Target

$22

2025-12-29

maintain

Outperform

Reason

Baird recommends buying shares of Alignment Healthcare on the recent pullback. The firm believes the company's fundamentals remain intact. The shares should perform well as investors return from the holiday season, the analyst tells investors in a research note. Baird says the Medicare Advantage trade "is on" and that Alignment is the "best way to play it." It sees no reason for the recent selloff and keeps an Outperform rating on the shares with a $22 price target.

JPMorgan

Overweight

maintain

$20 -> $23

2025-12-17

Reason

JPMorgan

Price Target

$20 -> $23

2025-12-17

maintain

Overweight

Reason

JPMorgan raised the firm's price target on Alignment Healthcare to $23 from $20 and keeps an Overweight rating on the shares. The firm adjusted targets in the healthcare services group as part of its 2026 outlook. JPMorgan sees "some reasons for optimism that managed care estimates are approaching trough levels." Most managed care companies will reach a trough in earnings in 2026 or have already reached a trough in earnings in 2025 with the potential for upward revisions going forward, the analyst tells investors in a research note.

JPMorgan

John Stansel

Neutral -> Overweight

upgrade

$18 -> $20

2025-11-24

Reason

JPMorgan

John Stansel

Price Target

$18 -> $20

2025-11-24

upgrade

Neutral -> Overweight

Reason

JPMorgan analyst John Stansel upgraded Alignment Healthcare to Overweight from Neutral with a price target of $20, up from $18, after assuming coverage of the name. The firm believes the company is positioned to be one of the "cleaner ways" to play Medicare Advantage into 2026. Alignment is continuing to gain share as its "differentiated" approach to care, stratification, and engagement supports recent cohort improvement, the analyst tells investors in a research note.

JPMorgan

Neutral

maintain

$17 -> $18

2025-11-05

Reason

JPMorgan

Price Target

$17 -> $18

2025-11-05

maintain

Neutral

Reason

JPMorgan raised the firm's price target on Alignment Healthcare to $18 from $17 and keeps a Neutral rating on the shares. The firm updated the company's model.

TD Cowen

Gary Taylor

Buy

maintain

$17

2025-11-03

Reason

TD Cowen

Gary Taylor

Price Target

$17

2025-11-03

maintain

Buy

Reason

TD Cowen analyst Gary Taylor raised the firm's price target on Alignment Healthcare to $18.50 from $17 and keeps a Buy rating on the shares. The firm updated its model following Q3 results as they raised their guidance for the fourth consecutive quarter since Q3 2024.

Valuation Metrics

The current forward P/E ratio for Alignment Healthcare Inc (ALHC.O) is 57.77, compared to its 5-year average forward P/E of -73.12. For a more detailed relative valuation and DCF analysis to assess Alignment Healthcare Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-73.12

Current PE

57.77

Overvalued PE

350.49

Undervalued PE

-496.73

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-80.21

Current EV/EBITDA

29.08

Overvalued EV/EBITDA

234.09

Undervalued EV/EBITDA

-394.50

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.26

Current PS

0.84

Overvalued PS

2.25

Undervalued PS

0.27

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areSelling! The selling amount has increased 1606.19% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ALHC News & Events

Events Timeline

No data

News

5.0

01-08Fool

Alignment Healthcare CIO Sells 69,541 Shares for Approximately $1.3 Million

5.0

01-08NASDAQ.COM

Alignment Healthcare CIO Sells 69,541 Shares for $1.3 Million

8.0

2025-12-19NASDAQ.COM

Options Trading for Alignment Healthcare (ALHC) in the First Week of August 2026

People Also Watch

Frequently Asked Questions

What is Alignment Healthcare Inc (ALHC) stock price today?

The current price of ALHC is 20.78 USD — it has decreased -0.81 % in the last trading day.

What is Alignment Healthcare Inc (ALHC)'s business?

Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.

What is the price predicton of ALHC Stock?

What is Alignment Healthcare Inc (ALHC)'s revenue for the last quarter?

Alignment Healthcare Inc revenue for the last quarter amounts to 993.70M USD, increased 43.51 % YoY.

What is Alignment Healthcare Inc (ALHC)'s earnings per share (EPS) for the last quarter?

Alignment Healthcare Inc. EPS for the last quarter amounts to 0.02 USD, decreased -114.29 % YoY.

What changes have occurred in the market's expectations for Alignment Healthcare Inc (ALHC)'s fundamentals?

How many employees does Alignment Healthcare Inc (ALHC). have?

Alignment Healthcare Inc (ALHC) has 1679 emplpoyees as of January 10 2026.

What is Alignment Healthcare Inc (ALHC) market cap?

Today ALHC has the market capitalization of 4.16B USD.